- Reaction score
- 460
Their human trial is to commence in March 2019, and they aim at a late 2020 (at best) conditional release. That's less than 22 months, in total.That makes sense. But where is this from?
Is there a source or did you just come up with it?
Anyone here know the legal implications of this not being a drug?
Phase I trials usually last about 12 months, and phase II ones about 12-24 months.
If time for approval is added (3-6 months), we get an >24 months timeframe.
That means that either their therapy can be approved after phase I trials or that they have merged the two phases into one. Both are probable, but I believe it's the latter.